Coronary artery spasm: mechanisms, risk factors, and translational strategies for precision management
Frontiers in Cardiovascular Medicine · 09.02.2026 · 13
DOI: 10.3389/fcvm.2026.1743355 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 09.02.2026. Verfasst von Zhihui Kuang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Guizhou Medical University, Guiyang, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Coronary artery spasm (CAS) is a major form of coronary vasomotor dysfunction within ischemia with non-obstructive coronary arteries (INOCA). Despite ethnic and geographic variation in prevalence, CAS is underrecognized because confirmation often requires pharmacological provocation testing that is unavailable in many centers. Clinically, CAS ranges from silent ischemia and angina to acute myocardial infarction, malignant arrhythmias, heart failure, and sudden cardiac death. Evidence suggests that spasm often occurs at sites with mild atherosclerosis and that its risk profile differs from atherosclerotic cardiovascular disease, with more consistent links to smoking, inflammatory burden, and genetic susceptibility, while associations with hypertension and diabetes remain inconsistent. Advances in invasive coronary function testing and recognition of microvascular spasm support an integrated framework involving endothelial dysfunction, vascular smooth muscle hyperreactivity, inflammation–oxidative stress, and autonomic dysregulation. This review synthesizes mechanistic and clinical evidence across these domains, highlights translational opportunities for phenotype-informed risk stratification and precision management, and outlines key research priorities to improve CAS care.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Clinical Medicine, Guizhou Medical University, Guiyang, China.
- The Key Laboratory of Myocardial Remodeling Research, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
- Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Cardiology, Chenzhou First People's Hospital, Chenzhou, China.
- Department of Cardiovascular Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Zitieren
APA
Kuang, Z., Kong, R., Wang, Z., Zuo, S., You, L., Wang, X., Si, X., & Liang, J. (2026). Coronary artery spasm: mechanisms, risk factors, and translational strategies for precision management. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1743355
Vancouver
Kuang Z, Kong R, Wang Z, Zuo S, You L, Wang X, et al. Coronary artery spasm: mechanisms, risk factors, and translational strategies for precision management. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1743355
BibTeX
@article{Kuang2026,
author = {Kuang, Zhihui and Kong, Ranran and Wang, Zhonghua and Zuo, Siying and You, Liwei and Wang, Xuan and Si, Xiaoyun and Liang, Jinfeng},
title = {Coronary artery spasm: mechanisms, risk factors, and translational strategies for precision management},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1743355}
}
EUVIMED